Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

@inproceedings{Coler2011DevelopmentAC,
  title={Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant},
  author={Rhea N Coler and Sylvie Bertholet and Magdalini Moutaftsi and Jeff A. Guderian and Hillarie Plessner Windish and Susan Baldwin and Elsa M. Laughlin and Malcolm Scott Duthie and Christopher B Fox and Darrick Carter and Martin Howell Friede and Thomas S. Vedvick and Steven G Reed},
  booktitle={PloS one},
  year={2011}
}
Innate immune responses to vaccine adjuvants based on lipopolysaccharide (LPS), a component of gram-negative bacterial cell walls, are driven by Toll-like receptor (TLR) 4 and adaptor proteins including MyD88 and TRIF, leading to the production of inflammatory cytokines, type I interferons, and chemokines. We report here on the characterization of a synthetic hexaacylated lipid A derivative, denoted as glucopyranosyl lipid adjuvant (GLA). We assessed the effects of GLA on murine and human… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 100 CITATIONS, ESTIMATED 57% COVERAGE

Ultra stable glassy state vaccines containing adjuvants

VIEW 17 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

Development of a highly thermostable, adjuvanted human papillomavirus vaccine.

  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
  • 2015
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism.

  • Journal of immunology
  • 2015
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2011
2019

CITATION STATISTICS

  • 20 Highly Influenced Citations

  • Averaged 6 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 49 REFERENCES

protects against experimental leishmaniasis

RN Coler, SL Baldwin, N Shaverdian, S Bertholet, SJ Reed
  • 2010